Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G-R Burmester

Showing results (351-360 of 380) with videos related to

Pageof 38
Sort By:
Annals of the Rheumatic Diseases|October 22, 2005
Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005D E Furst, F C Breedveld, J R Kalden, et al.
Arthritis and Rheumatism|August 29, 2009
Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot projectM Backhaus, S Ohrndorf, H Kellner, et al.
Annals of the Rheumatic Diseases|October 28, 2006
Consensus statement on the use of rituximab in patients with rheumatoid arthritisJ S Smolen, E C Keystone, P Emery, et al.
Annals of the Rheumatic Diseases|November 19, 2008
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trialJ Smolen, R B Landewé, P Mease, et al.
Rheumatology (Oxford, England)|December 6, 2008
Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) RegisterL G Hanitsch, G-R Burmester, C Witt, et al.
Arthritis Research & Therapy|August 5, 2022
The MCP2 and the wrist plus two extensor compartments are the most affected and responsive joints/tendons out of the US7 score in patients with rheumatoid arthritis-an observational studyA F Podewski, A M Glimm, I Fischer, et al.
Annals of the Rheumatic Diseases|January 8, 2009
Periodontal disease in patients with ankylosing spondylitisN Pischon, T Pischon, E Gülmez, et al.
Annals of the Rheumatic Diseases|April 5, 2008
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapiesE Keystone, P Emery, C G Peterfy, et al.
Annals of the Rheumatic Diseases|October 14, 2006
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006D E Furst, F C Breedveld, J R Kalden, et al.
Annals of the Rheumatic Diseases|August 17, 2004
EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committeesM Dougados, N Betteridge, G R Burmester, et al.
Pageof 38

Showing results (351-360 of 380) with videos related to

Sort By:
Pageof 38
Annals of the Rheumatic Diseases|October 22, 2005
Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005D E Furst, F C Breedveld, J R Kalden, et al.
Arthritis and Rheumatism|August 29, 2009
Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot projectM Backhaus, S Ohrndorf, H Kellner, et al.
Annals of the Rheumatic Diseases|October 28, 2006
Consensus statement on the use of rituximab in patients with rheumatoid arthritisJ S Smolen, E C Keystone, P Emery, et al.
Annals of the Rheumatic Diseases|November 19, 2008
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trialJ Smolen, R B Landewé, P Mease, et al.
Rheumatology (Oxford, England)|December 6, 2008
Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) RegisterL G Hanitsch, G-R Burmester, C Witt, et al.
Arthritis Research & Therapy|August 5, 2022
The MCP2 and the wrist plus two extensor compartments are the most affected and responsive joints/tendons out of the US7 score in patients with rheumatoid arthritis-an observational studyA F Podewski, A M Glimm, I Fischer, et al.
Annals of the Rheumatic Diseases|January 8, 2009
Periodontal disease in patients with ankylosing spondylitisN Pischon, T Pischon, E Gülmez, et al.
Annals of the Rheumatic Diseases|April 5, 2008
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapiesE Keystone, P Emery, C G Peterfy, et al.
Annals of the Rheumatic Diseases|October 14, 2006
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006D E Furst, F C Breedveld, J R Kalden, et al.
Annals of the Rheumatic Diseases|August 17, 2004
EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committeesM Dougados, N Betteridge, G R Burmester, et al.
Pageof 38